经皮肝穿胆道引流及支架植入治疗恶性梗阻性黄疸

来源 :中国伤残医学 | 被引量 : 0次 | 上传用户:ycx20080907
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨经皮肝穿胆道内外引流及支架植入治疗恶性梗阻性黄疸的临床疗效。方法 :在C型臂下,16例恶性梗阻性黄疸患者采用经皮肝穿胆道内外引流及支架植入治疗。结果:16例患者中,14例1次行支架植入成功,2例因导丝不能通过狭窄先行外引流1周后再行支架植入成功。术后患者黄疸均得到不同程度改善,1例发生少量的胸腔积液。结论:经皮肝穿胆道引流及支架植入治疗恶性梗阻性黄疸疗效可靠,创伤小,缓解症状快,并发症少,可明显提高患者生活质量,延长生存时间。 Objective: To investigate the clinical efficacy of percutaneous transhepatic biliary drainage and stent implantation in the treatment of malignant obstructive jaundice. Methods: Under C arm, 16 patients with malignant obstructive jaundice were treated with percutaneous transhepatic biliary drainage and stent implantation. Results: Out of the 16 patients, 14 cases were successfully implanted in the first stent and 2 cases were successfully implanted after 2 weeks because the guide wire could not pass the stenosis. Patients with jaundice were improved to varying degrees, 1 case of a small amount of pleural effusion. Conclusion: Percutaneous transhepatic biliary drainage and stent implantation in the treatment of malignant obstructive jaundice have reliable curative effects, small trauma, quick response to symptoms and few complications. They can significantly improve patients’ quality of life and prolong their survival time.
其他文献
会议
系统性红斑狼疮(SLE)是一种表现复杂的慢性自身免疫性疾病,其治疗主要以糖皮质激素和免疫抑制剂为主。近年来,治疗SLE的生物制剂不断涌现,为SLE的治疗提供了新的选择。综述生
会议
会议
文章以乌鲁木齐市水务(集团)有限公司污水处理公司产生的城市污泥为研究对象,对该污泥中的重金属含量和赋存形态进行了分析,并以新疆地产膨润土对污泥中的重金属进行了稳定化